Skip to main content
/health
  • Share this on:
    Share
  • E-mail
  • Save
  • Print

Trial: Popular cholesterol drug fails to improve heart disease

  • Story Highlights
  • Trial: Vytorin failed to improve heart disease though it reduces key risk factors
  • Millions of Americans already take the drug or one of its components, Zetia
  • Yale University cardiologist: People need to return to statins, like Lipitor
  • Zetia, Vytorin have racked up $5 billion in sales despite limited proof of benefit
  • Next Article in Health »
  • E-mail
  • Save
  • Print
Quick Job Search
keyword(s):
enter city:
Home  |  World  |  U.S.  |  Politics  |  Crime  |  Entertainment  |  Health  |  Tech  |  Travel  |  Living  |  Business  |  Sports  |  Time.com
© 2008 Cable News Network. Turner Broadcasting System, Inc. All Rights Reserved.